Company intelligence / Profile preview

Hairstetics

Ownership: Private
Employees: ~75
Development stage: Other

Overview

Hairstetics has developed a minimally invasive, non-surgical hair implant device with an anchoring system designed to treat androgenetic alopecia and other forms of hair loss. The procedure takes less than an hour with no downtime. Clinical studies have focused on safety and efficacy in women with female pattern hair loss. The company holds CE mark and ANVISA certification, has begun initial sales, and won the 2021 IMCAS Innovation of the Year award.

Therapeutic areas: Dermatology
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Hairstetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hairstetics.

Explore the full profile